Status:
COMPLETED
Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
Lead Sponsor:
Georgetown University
Conditions:
Persian Gulf Syndrome
Eligibility:
All Genders
34-82 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to perform a randomized double-blind, placebo-controlled, 12 week study of the effects of carnosine on cognitive, psychometric, autonomic, and muscle strength outcomes in ...
Detailed Description
Background: Homocarnosine (beta-alanine - gamma-aminobutyric acid) is one of the most abundant dipeptides in the brain. It has important antioxidant properties. Both beta-alanine and GABA are neurotra...
Eligibility Criteria
Inclusion
- Evidence of military enlistment between August 1, 1990 and July 31, 1991, and deployment for 30 consecutive days to:
- Persian Gulf waters and adjacent land areas,
- Other global locations, or,
- U.S. only. 1990-1991 enlistment status:
- Active duty
- National Guard
- Reserves
Exclusion
- HIV/AIDS
- Pregnant Women
- Active Duty Military Personnel
- Children
- Incarceration
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00810368
Start Date
August 1 2008
End Date
July 1 2012
Last Update
June 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University
Washington D.C., District of Columbia, United States, 20007